Company:  GERON CORP (GERN)
Form Type:  SC 13G/A
Filing Date:  2/17/1998 
CIK:  0000886744 
Address:  149 COMMONWEALTH DRIVE
SUITE 2070
 
City, State, Zip:  MENLO PARK, California 94025 
Telephone:  (650) 473-7700 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$3.68  
Change: 
-0.04 (-1.08%)  
Trade Time: 
Nov 28  
Market Cap: 
$578.54M
Description of Business
We are a clinical stage biopharmaceutical company developing a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. Through a combined strategy of internal efforts and potential future strategic partnerships, we intend to advance the development and commercialization of imetelstat in one or more hematologic myeloid malignancies. The discovery and early development of imetelstat, our sole product candidate, was based on our core expertise in telomerase and telomere biology. Telomerase is an enzyme that enables cancer cells, including malignant progenitor cells, to maintain telomere length, which provides them with the capacity for limitless, uncontrolled proliferation. 3 -------------------------------------------------------------------------------- Table of Contents Imetelstat is a potent and specific inhibitor of telomerase.
Register for EDGAR Pro and access this filing in:     
  FORM SC 13G/A
BROKERAGE PARTNERS